Virtual identification of novel PPARα/γ dual agonists by 3D-QSAR, molecule docking and molecular dynamics studies

References

• Abbasi, M., Sadeghi-Aliabadi, H., & Amanlou, M. (2018). 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold. Journal of Biomolecular Structure and Dynamics, 36(6), 1463–1478. doi:10.1080/07391102.2017.1326319
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani, M. A., Jayyousi, A., DeFronzo, R. A., Asaad, N., & Al-Suwaidi, J. (2019). Insulin resistance the link between T2DM and CVD: Basic mechanisms and clinical implications. Current Vascular Pharmacology, 17(2), 153–163. doi:10.2174/1570161115666171010115119
   PubMed Web of Science ®Google Scholar
• Aouidate, A., Ghaleb, A., Ghamali, M., Chtita, S., Ousaa, A., Choukrad, M. B., … Lakhlifi, T. (2018). Furanone derivatives as new inhibitors of CDC7 kinase: Development of structure activity relationship model using 3D QSAR, molecular docking, and in silico ADMET. Structural Chemistry, 29(4), 1031–1043. doi:10.1007/s11224-018-1086-4
   Web of Science ®Google Scholar
• Cheng, D., Gao, H., & Li, W. (2018). Long-term risk of rosiglitazone on cardiovascular events – A systematic review and meta-analysis. Endokrynologia Polska, 69(4), 381–394.
   PubMed Web of Science ®Google Scholar
• Choi, B. H., Jin, Z., Yi, C. O., Oh, J., Jeong, E. A., Lee, J. Y., … Roh, G. S. (2018). Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice. PLoS One, 13(7), e0200336. doi:10.1371/journal.pone.0200336
   PubMed Web of Science ®Google Scholar
• Coletta, D. K., Fernandez, M., Cersosimo, E., Gastaldelli, A., Musi, N., & DeFronzo, R. A. (2015). The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo. Diabetic Medicine, 32(5), 657–664. doi:10.1111/dme.12664
   PubMed Web of Science ®Google Scholar
• Cronet, P., Petersen, J. F., Folmer, R., Blomberg, N., Sjoblom, K., Karlsson, U., … Bamberg, K. (2001). Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure, 9, 699–706. doi:10.1016/S0969-2126(01)00634-7
   PubMed Web of Science ®Google Scholar
• D’Orio, B., Fracassi, A., Ceru, M. P., & Moreno, S. (2018). Targeting PPARalpha in Alzheimer’s disease. Current Alzheimer Research, 15(4), 345–354. doi:10.2174/1567205014666170505094549
   PubMed Web of Science ®Google Scholar
• Du, F., Li, D., Piao, L. S., & Yang, K. J. (2018). Association of sLR11 gene polymorphism with T2DM and carotid atherosclerosis. Technology and Health Care, 26(3), 391–400. doi:10.3233/THC-171040
   PubMed Web of Science ®Google Scholar
• Floresta, G., Cilibrizzi, A., Abbate, V., Spampinato, A., Zagni, C., & Rescifina, A. (2019). 3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation. Bioorganic Chemistry, 84, 276–284. doi:10.1016/j.bioorg.2018.11.045
   PubMed Web of Science ®Google Scholar
• Furue, K., Mitoma, C., Tsuji, G., & Furue, M. (2018). Protective role of peroxisome proliferator-activated receptor alpha agonists in skin barrier and inflammation. Immunobiology, 223(3), 327–330. doi:10.1016/j.imbio.2017.10.047
   PubMed Web of Science ®Google Scholar
• Gim, H. J., Choi, Y. S., Li, H., Kim, Y. J., Ryu, J. H., & Jeon, R. (2018). Identification of a novel PPAR-gamma agonist through a Scaffold tuning approach. International Journal of Molecular Sciences, 19(10), 3032. doi:10.3390/ijms19103032
   Web of Science ®Google Scholar
• Hashimoto, Y., & Miyachi, H. (2005). Nuclear receptor antagonists designed based on the helix-folding inhibition hypothesis. Bioorganic & Medicinal Chemistry, 13, 5080–5093. doi:10.1016/j.bmc.2005.03.027
   PubMed Web of Science ®Google Scholar
• Huang, C., Zhong, Q., Tang, L., Wang, H., Xu, J., & Zhou, Z. (2019). Discovery of 2-(3,4-dialkoxyphenyl)-2-(substituted pyridazin-3-yl)acetonitriles as phosphodiesterase 4 inhibitors with anti-neuroinflammation potential based on three-dimensional quantitative structure-activity relationship study. Chemical Biology & Drug Design, 93, 484–502. doi:10.1111/cbdd.13438
   PubMed Web of Science ®Google Scholar
• Jian, Y., He, Y., Yang, J., Han, W., Zhai, X., Zhao, Y., … Li, Y. (2018). Molecular modeling study for the design of novel peroxisome proliferator-activated receptor gamma agonists using 3D-QSAR and molecular docking. International Journal of Molecular Sciences, 19(2), 630. doi:10.3390/ijms19020630
   Web of Science ®Google Scholar
• Jung, H. Y., Kim, B., Ryu, H. G., Ji, Y., Park, S., Choi, S. H., … Kim, K. T. (2018). Amodiaquine improves insulin resistance and lipid metabolism in diabetic model mice. Diabetes, Obesity and Metabolism, 20(7), 1688–1701. doi:10.1111/dom.13284
   PubMed Web of Science ®Google Scholar
• Katari, S. K., Natarajan, P., Swargam, S., Kanipakam, H., Pasala, C., & Umamaheswari, A. (2016). Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations. Journal of Receptors and Signal Transduction, 36(6), 558–571. doi:10.3109/10799893.2016.1141955
   PubMed Web of Science ®Google Scholar
• Khan, I. A., Jahan, P., Hasan, Q., & Rao, P. (2019). Genetic confirmation of T2DM meta-analysis variants studied in gestational diabetes mellitus in an Indian population. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(1), 688–694. doi:10.1016/j.dsx.2018.11.035
   PubMed Web of Science ®Google Scholar
• Khuchua, Z., Glukhov, A. I., Strauss, A. W., & Javadov, S. (2018). Elucidating the beneficial role of PPAR agonists in cardiac diseases. International Journal of Molecular Sciences, 19(11), 3464. doi:10.3390/ijms19113464
   Web of Science ®Google Scholar
• Laghezza, A., Piemontese, L., Cerchia, C., Montanari, R., Capelli, D., Giudici, M., … Loiodice, F. (2018). Identification of the first PPARalpha/gamma dual agonist able to bind to canonical and alternative sites of PPARgamma and to inhibit its Cdk5-mediated phosphorylation. Journal of Medicinal Chemistry, 61(18), 8282–8298. doi:10.1021/acs.jmedchem.8b00835
   PubMed Web of Science ®Google Scholar
• Li, J. J., Zhang, P., Fan, B., Guo, X. L., & Zheng, Z. S. (2019). The efficacy of saxagliptin in T2DM patients with non-alcoholic fatty liver disease: Preliminary data. Revista da Associação Médica Brasileira), 65(1), 33–37. doi:10.1590/1806-9282.65.1.33
   PubMed Web of Science ®Google Scholar
• Li, S., Yang, B., Du, Y., Lin, Y., Liu, J., Huang, S., … Zhang, Y. (2018). Targeting PPARalpha for the treatment and understanding of cardiovascular diseases. Cellular Physiology and Biochemistry, 51(6), 2760–2775. doi:10.1159/000495969
   PubMedGoogle Scholar
• Mandal, S. P., Garg, A., Prabitha, P., Wadhwani, A. D., Adhikary, L., & Kumar, B. R. P. (2018). Novel glitazones as PPARγ agonists: Molecular design, synthesis, glucose uptake activity and 3D QSAR studies. Chemistry Central Journal, 12(1), 141. doi:10.1186/s13065-018-0508-0
   PubMedGoogle Scholar
• Min, M., Xingjun, J., Xueding, W., Hao, Z., Weiqing, Y., Yuanyuan, Z., … Menglin, M. (2016). Synthesis and quantitative structure-activity relationships study for arylpropenamide derivatives as inhibitors of hepatitis B virus replication. Chemical Biology & Drug Design, 88, 451–459. doi:10.1111/cbdd.12774
   PubMed Web of Science ®Google Scholar
• Modi, P., Patel, S., & Chhabria, M. T. (2019). Identification of some novel pyrazolo[1,5-a]pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking. Journal of Biomolecular Structure and Dynamics, 37(7), 1736–1749. doi:10.1080/07391102.2018.1465852
   PubMed Web of Science ®Google Scholar
• Nanjan, M. J., Mohammed, M., Prashantha, K. B., & Chandrasekar, M. (2018). Thiazolidinediones as antidiabetic agents: A critical review. Bioorganic Chemistry, 77, 548–567. doi:10.1016/j.bioorg.2018.02.009
   PubMed Web of Science ®Google Scholar
• Pardhi, T., & Vasu, K. (2018). Identification of dual kinase inhibitors of CK2 and GSK3beta: Combined qualitative and quantitative pharmacophore modeling approach. Journal of Biomolecular Structure and Dynamics, 36(1), 177–194. doi:10.1080/07391102.2016.1270856
   PubMed Web of Science ®Google Scholar
• Safarizadeh, H., & Garkani-Nejad, Z. (2019). Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer’s amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors. Journal of Molecular Graphics and Modelling, 87, 129–143. doi:10.1016/j.jmgm.2018.11.019
   PubMed Web of Science ®Google Scholar
• Saxena, S., Abdullah, M., Sriram, D., & Guruprasad, L. (2018). Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: Homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 36(12), 3184–3198. doi:10.1080/07391102.2017.1384398
   PubMed Web of Science ®Google Scholar
• Sharifi, T., & Ghayeb, Y. (2018). A computational study to identify the key residues of peroxisome proliferator-activated receptor gamma in the interactions with its antagonists. Journal of Biomolecular Structure and Dynamics, 36(7), 1822–1833. doi:10.1080/07391102.2017.1335618
   PubMed Web of Science ®Google Scholar
• Sheikh, I. A., Jiffri, E. H., Ashraf, G. M., & Kamal, M. A. (2019). Structural insights into the camel milk lactoperoxidase: Homology modeling and molecular dynamics simulation studies. Journal of Molecular Graphics and Modelling, 86, 43–51. doi:10.1016/j.jmgm.2018.10.008
   PubMed Web of Science ®Google Scholar
• Shen, J., Yang, T., Xu, Y., Luo, Y., Zhong, X., Shi, L., … Lin, Q. (2018). Delta-tocotrienol, isolated from rice bran, exerts an anti-inflammatory effect via MAPKs and PPARs signaling pathways in lipopolysaccharide-stimulated macrophages. International Journal of Molecular Sciences, 19(10), 3022. doi:10.3390/ijms19103022
   Web of Science ®Google Scholar
• Sherin, D. R., Geethu, C. K., Prabhakaran, J., Mann, J. J., Dileep Kumar, J. S., & Manojkumar, T. K. (2019). Molecular docking, dynamics simulations and 3D-QSAR modeling of arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR agonists. Computational Biology and Chemistry, 78, 108–115. doi:10.1016/j.compbiolchem.2018.11.015
   PubMed Web of Science ®Google Scholar
• Shi, S., Zhao, L., & Zheng, L. (2018). NSD2 is downregulated in T2DM and promotes beta cell proliferation and insulin secretion through the transcriptionally regulation of PDX1. Molecular Medicine Reports, 18(3), 3513–3520.
   PubMed Web of Science ®Google Scholar
• Shibata, Y., Kagechika, K., Ota, M., Yamaguchi, M., Setoguchi, M., Kubo, H., … & Usui, H. (2015). Synthesis and structure-activity relationships of 2-aminoacetamide derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists. Chemical & Pharmaceutical Bulletin, 63(8), 591–602. doi:10.1248/cpb.c15-00221
   PubMed Web of Science ®Google Scholar
• Shibata, Y., Kagechika, K., Yamaguchi, M., Yoshikawa, K., Chiba, K., Takano, H., … Usui, H. (2013). Synthesis and structure-activity relationships of novel zwitterionic compounds as peroxisome proliferator activated receptor alpha/gamma dual agonists with improved physicochemical properties. Chemical and Pharmaceutical Bulletin, 61(12), 1248–1263. doi:10.1248/cpb.c13-00513
   PubMed Web of Science ®Google Scholar
• Thillainayagam, M., Malathi, K., Anbarasu, A., Singh, H., Bahadur, R., & Ramaiah, S. (2019). Insights on inhibition of Plasmodium falciparum plasmepsin I by novel epoxyazadiradione derivatives – Molecular docking and comparative molecular field analysis. Journal of Biomolecular Structure & Dynamics, 37, 3168–3182.
   PubMed Web of Science ®Google Scholar
• Tong, L., Guo, L., Lv, X., & Li, Y. (2017). Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure–activity relationship models. Journal of Molecular Graphics and Modelling, 71, 1–12. doi:10.1016/j.jmgm.2016.10.012
   PubMed Web of Science ®Google Scholar
• Vetter, C., & Scheer, F. (2019). A healthy lifestyle – Reducing T2DM risk in shift workers? Nature Reviews. Endocrinology, 15(4), 194–196. doi:10.1038/s41574-019-0164-z
   PubMed Web of Science ®Google Scholar
• Vora, J., Patel, S., Sinha, S., Sharma, S., Srivastava, A., Chhabria, M., … Shrivastava, N. (2019). Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV. Journal of Biomolecular Structure and Dynamics, 37(1), 131–146. doi:10.1080/07391102.2017.1420489
   PubMed Web of Science ®Google Scholar
• Wang, F., Hu, X., & Zhou, B. (2019). Structural characterization of Plasmodial aminopeptidase: A combined molecular docking and QSAR-based in silico approaches. Molecular Diversity, 1–20. doi:10.1007/s11030-019-09921-y
   PubMed Web of Science ®Google Scholar
• Wang, M., Liang, J., Olounfeh, K., Sun, Q., Zhao, N., & Meng, F. (2018). A comprehensive in silico method to study the QSTR of the aconitine alkaloids for designing novel drugs. Molecules, 23(9), 2385. doi:10.3390/molecules23092385
   Web of Science ®Google Scholar
• Yang, J., Ma, M., Wang, X., Jiang, X., Zhang, Y., Yang, W., … & Ma, M. (2015). Synthesis and quantitative structure–activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication. European Journal of Medicinal Chemistry, 99, 82–91. doi:10.1016/j.ejmech.2015.05.032
   PubMed Web of Science ®Google Scholar
• Zhang, C., Zhang, H., Huang, L. S., Zhu, S., Xu, Y., Zhang, X., … An, J. (2018). Virtual screening, biological evaluation, and 3D-QSAR studies of new HIV-1 entry inhibitors that function via the CD4 primary receptor. Molecules, 23(11), 3036. doi:10.3390/molecules23113036
   Web of Science ®Google Scholar
• Zhuo, X., Zhang, C., Feng, J., Ouyang, S., Niu, P., & Dai, Z. (2019). In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention: A meta-analysis including 139,774 patients. Medicine (Baltimore), 98(8), e14669. doi:10.1097/MD.0000000000014669
   PubMed Web of Science ®Google Scholar